van Dongen William D, Renfurm Luuk C
TNO Triskelion BV, Utrechtseweg 48, 3704 AV Zeist, The Netherlands.
Bioanalysis. 2014 May;6(9):1159-65. doi: 10.4155/bio.14.53.
The 6th European Bioanalysis Forum Open Meeting 20-22 November 2013, Hesperia Tower Hotel, Barcelona, Spain At the 6th European Bioanalysis Forum Open Meeting, held from 20-22 November 2013 in Hesperia Tower Hotel, Barcelona, Spain, bioanalytical experts from pharmaceutical industry, academia, contract laboratories and regulatory bodies discussed current topics of interest in bioanalysis. 450 delegates from more than 170 institutes and companies participated in 75 open and stimulating presentations regarding the new US FDA Guidance for industry, technology updates, including liquid chromatography-mass spectrometry of proteins and antibody-drug conjugates, dried blood spots, sampling and extraction and regulatory aspects of, for example, flow cytometry, parallelism, and interferences in ligand-binding assays. This article aims to provide an overview of the highlights discussed at the meeting.
第六届欧洲生物分析论坛公开会议,2013年11月20日至22日,西班牙巴塞罗那赫斯珀里亚塔楼酒店
在2013年11月20日至22日于西班牙巴塞罗那赫斯珀里亚塔楼酒店举行的第六届欧洲生物分析论坛公开会议上,来自制药行业、学术界、合同实验室和监管机构的生物分析专家讨论了生物分析领域当前感兴趣的话题。来自170多家机构和公司的450名代表参加了75场公开且富有启发性的演讲,内容涉及美国食品药品监督管理局(FDA)针对行业的新指南、技术更新,包括蛋白质和抗体 - 药物偶联物的液相色谱 - 质谱分析、干血斑、采样与提取,以及例如流式细胞术、平行性和配体结合分析中的干扰等监管方面。本文旨在概述会议上讨论的要点。